Neurocrine Biosciences (NBIX) had the highest return between January 1, 2014 and June 30, 2015 by a large-cap US stock, returning 415.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Neurocrine Biosciences (NBIX) | 1/1/2014 - 6/30/2015 | 415.21% |
Skyworks Solutions (SWKS) | 1/1/2014 - 6/30/2015 | 271.48% |
Intracellular Th (ITCI) | 1/1/2014 - 6/30/2015 | 219.5% |
Palo Alto Networks (PANW) | 1/1/2014 - 6/30/2015 | 208.06% |
Electronic Arts (EA) | 1/1/2014 - 6/30/2015 | 190.39% |
Centene (CNC) | 1/1/2014 - 6/30/2015 | 172.73% |
Broadcom (AVGO) | 1/1/2014 - 6/30/2015 | 156.96% |
CyberArk Software (CYBR) | 1/1/2014 - 6/30/2015 | 151.28% |
DexCom (DXCM) | 1/1/2014 - 6/30/2015 | 126.89% |
NXP Semiconductors (NXPI) | 1/1/2014 - 6/30/2015 | 119.69% |
Edwards Lifesciences (EW) | 1/1/2014 - 6/30/2015 | 116.85% |
Genmab A-S (GMAB) | 1/1/2014 - 6/30/2015 | 116.2% |
Fortinet (FTNT) | 1/1/2014 - 6/30/2015 | 115.71% |
Coca-Cola Consolidated (COKE) | 1/1/2014 - 6/30/2015 | 110.89% |
Axon Enterprise (AXON) | 1/1/2014 - 6/30/2015 | 110.29% |
Incyte (INCY) | 1/1/2014 - 6/30/2015 | 107.09% |
Zebra Technologies (ZBRA) | 1/1/2014 - 6/30/2015 | 106.26% |
Manhattan Associates (MANH) | 1/1/2014 - 6/30/2015 | 103.74% |
Molina Healthcare (MOH) | 1/1/2014 - 6/30/2015 | 100.86% |
Illumina (ILMN) | 1/1/2014 - 6/30/2015 | 97.65% |
Monster Beverage (MNST) | 1/1/2014 - 6/30/2015 | 97.44% |
Biomarin Pharmaceutical (BMRN) | 1/1/2014 - 6/30/2015 | 95.09% |
NetEase (NTES) | 1/1/2014 - 6/30/2015 | 91.8% |
HCA (HCA) | 1/1/2014 - 6/30/2015 | 91.43% |
Paycom Soft (PAYC) | 1/1/2014 - 6/30/2015 | 90.78% |
Large-cap stocks are treated as having a market cap of $10B+.
